ConductScience.org, home

Paper29700554

Platelet-rich plasma as an additional therapeutic option for infected wounds with multi-drug resistant bacteria: in vitro antibacterial activity study.

Çetinkaya RA and 8 others. Eur J Trauma Emerg Surg, 2019. Cited by 32 papers, by iCite.

Cite this record

ConductScience Library. Platelet-rich plasma as an additional therapeutic option for infected wounds with multi-drug resistant bacteria: in vitro antibacterial activity study. Papers, record 29700554. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/29700554

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Platelet-rich plasma as an additional therapeutic option for infected wounds with multi-drug resistant bacteria: in vitro antibacterial activity study.
PubMed
Journal
Eur J Trauma Emerg Surg
PubMed
Year
2019
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
32
iCite
Relative citation ratio, by iCite
2.36
iCite
Revised in PubMed
2024-11-05
PubMed

Authors9

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Çetinkaya RARıza Aytaç
2Yenilmez EErcan
3Petrone PPatriziohttps://orcid.org/0000-0002-7629-1663
4Yılmaz SSoner
5Bektöre BBayhan
6Şimsek BBerksan
7Kula Atik TTuğba
8Özyurt MMustafa
9Ünlü AAytekin

Source PubMed

Download CSV of authors

Topics17

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Drug Resistance, Multiple, BacterialMajor topic
Klebsiella pneumoniaeMajor topic
Methicillin-Resistant Staphylococcus aureusMajor topic
Platelet-Rich PlasmaMajor topic
Pseudomonas aeruginosaMajor topic
Vancomycin-Resistant EnterococciMajor topic
Adult
Carbapenems
Female
Healthy Volunteers
Humans
In Vitro Techniques
Male
Microbial Sensitivity Tests
Plasma
Wound Infection
beta-Lactamases

Source PubMed

Download CSV of topics

References31

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
110564562Efficacy and safety of becaplermin (recombinant human platelet-derived growth factor-BB) in patients with nonhealing, lower extremity diabetic ulcers: a combined analysis of four randomized studies.Wound Repair Regen1999https://conductscience.org/library/papers/10564562PubMed
213789187Cellular source and charcter of a heatstable bactericidal property associated with rabbit and rat platelets.J Exp Med1961https://conductscience.org/library/papers/13789187PubMed
315150818A report from the international consensus on diagnosing and treating the infected diabetic foot.Diabetes Metab Res Rev2004https://conductscience.org/library/papers/15150818PubMed
417356164Antibacterial effect of autologous platelet gel enriched with growth factors and other active substances: an in vitro study.J Bone Joint Surg Br2007https://conductscience.org/library/papers/17356164PubMed
517960651Antimicrobial activity of platelet-leukocyte gel against Staphylococcus aureus.J Orthop Res2008https://conductscience.org/library/papers/17960651PubMed
619994800Diabetes and peripheral vascular disease.Acta Chir Belg2009https://conductscience.org/library/papers/19994800PubMed
720013024Platelets in defense against bacterial pathogens.Cell Mol Life Sci2010https://conductscience.org/library/papers/20013024PubMed
821073293Current medical management of diabetic foot infections.Expert Rev Anti Infect Ther2010https://conductscience.org/library/papers/21073293PubMed
921847007Enhanced skin wound healing by a sustained release of growth factors contained in platelet-rich plasma.Exp Mol Med2011https://conductscience.org/library/papers/21847007PubMed
1022329713Antibacterial effect of plasma rich in growth factors (PRGF®-Endoret®) against Staphylococcus aureus and Staphylococcus epidermidis strains.Clin Exp Dermatol2012https://conductscience.org/library/papers/22329713PubMed
1123442413Antimicrobial activity of pure platelet-rich plasma against microorganisms isolated from oral cavity.BMC Microbiol2013https://conductscience.org/library/papers/23442413PubMed
1223447088Unique antimicrobial effects of platelet-rich plasma and its efficacy as a prophylaxis to prevent implant-associated spinal infection.Adv Healthc Mater2013https://conductscience.org/library/papers/23447088PubMed
1323609458PRP as a new approach to prevent infection: preparation and in vitro antimicrobial properties of PRP.J Vis Exp2013https://conductscience.org/library/papers/23609458PubMed
1423671863Antibacterial effect of autologous platelet-rich gel derived from subjects with diabetic dermal ulcers in vitro.J Diabetes Res2013https://conductscience.org/library/papers/23671863PubMed
1523759113Platelet-rich plasma preparation for regenerative medicine: optimization and quantification of cytokines and growth factors.Stem Cell Res Ther2013https://conductscience.org/library/papers/23759113PubMed
1624830471Platelets: at the nexus of antimicrobial defence.Nat Rev Microbiol2014https://conductscience.org/library/papers/24830471PubMed
1725108654Platelet-rich plasma affects bacterial growth in vitro.Cytotherapy2014https://conductscience.org/library/papers/25108654PubMed
1825345340Antimicrobial activity of platelet-rich plasma and other plasma preparations against periodontal pathogens.J Periodontol2015https://conductscience.org/library/papers/25345340PubMed
1925722595Principles and Methods of Preparation of Platelet-Rich Plasma: A Review and Author's Perspective.J Cutan Aesthet Surg2014https://conductscience.org/library/papers/25722595PubMed
2026238676Combating Superbug Without Antibiotic on a Postamputation Wound in a Patient with Diabetic Foot.Int J Low Extrem Wounds2016https://conductscience.org/library/papers/26238676PubMed

See all 31 referencesDownload CSV of references

Cited by27

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 32 citations.

PMIDTitleJournalYearIn PapersSource
42827678Platelet-rich therapies in cutaneous and mucocutaneous disorders characterized by inflammatory tissue responses: mechanistic insights and clinical evidence.Front Med (Lausanne)2026https://conductscience.org/library/papers/42827678PubMed
41704954In vitro antibacterial activity of platelet-rich plasma against Gram-positive and Gram-negative pathogens.Front Cell Infect Microbiol2026https://conductscience.org/library/papers/41704954PubMed
41507966Risk prediction of encephalitis in hand, foot and mouth disease: a nomogram model based on platelet indices for resource-limited settings.Ital J Pediatr2026https://conductscience.org/library/papers/41507966PubMed
41361815Antibacterial and antibiofilm activity of platelet-rich plasma under different activation conditions against multidrug-resistant MRSA isolated from human skin abscesses.BMC Biotechnol2025https://conductscience.org/library/papers/41361815PubMed
41210507Progress in the clinical application of allogeneic platelet-rich plasma for diabetic foot treatment.Front Endocrinol (Lausanne)2025https://conductscience.org/library/papers/41210507PubMed
40612051Consensus on the Diagnosis and Treatment of Adult Necrotizing Fasciitis (2025 Edition).Burns Trauma2025https://conductscience.org/library/papers/40612051PubMed
40307308Platelet-rich plasma as a potential antimicrobial agent against multidrug-resistant bacteria in diabetic foot infections.Sci Rep2025https://conductscience.org/library/papers/40307308PubMed
40213115Comparative analysis of cytokine profiles in canine injectable platelet-rich fibrin and platelet-rich plasma.Int J Vet Sci Med2025https://conductscience.org/library/papers/40213115PubMed
40166040Platelet concentrates in diabetic foot ulcers: A comparative review of PRP, PRF, and CGF with case insights.Regen Ther2025https://conductscience.org/library/papers/40166040PubMed
39729010Antibacterial Effect of Canine Leucocyte Platelet-Rich Plasma (L-PRP) and Canine Platelet-Poor Plasma (PPP) Against Methicillin-Sensitive and Methicillin-Resistant Staphylococcus pseudintermedius.Vet Sci2024https://conductscience.org/library/papers/39729010PubMed
39448627Efficacy and safety of allogeneic platelet-rich plasma in chronic wound treatment: a meta-analysis of randomized controlled trials.Sci Rep2024https://conductscience.org/library/papers/39448627PubMed
39369241Platelet-rich fibrin in the management of oral mucosal lesions: a scoping review.BMC Oral Health2024https://conductscience.org/library/papers/39369241PubMed
38732057An In Vitro Study on the Application of Silver-Doped Platelet-Rich Plasma in the Prevention of Post-Implant-Associated Infections.Int J Mol Sci2024https://conductscience.org/library/papers/38732057PubMed
38139380The Potential of Sheep or Camel Milk Constituents to Contribute to Novel Dressings for Diabetic Wounds.Int J Mol Sci2023https://conductscience.org/library/papers/38139380PubMed
38033816A review of platelet-rich plasma for enteric fistula management.Front Bioeng Biotechnol2023https://conductscience.org/library/papers/38033816PubMed
37570265Platelet- Rich Plasma Treatment Supported by Ultrasound Detection of Septa in Recurrent Canine Aural Hematoma: A Case Series.Animals (Basel)2023https://conductscience.org/library/papers/37570265PubMed
36143034Effect of Platelet-Rich Plasma Augmentation on Endoscopy-Assisted Percutaneous Achilles Tendon Repair.J Clin Med2022https://conductscience.org/library/papers/36143034PubMed
34680774Use of Intravesical Injections of Platelet-Rich Plasma for the Treatment of Bladder Pain Syndrome: A Comprehensive Literature Review.Antibiotics (Basel)2021https://conductscience.org/library/papers/34680774PubMed
34671662Antibacterial Properties of Canine Platelet-Rich Plasma and Other Non-Transfusional Hemo-Components: An in vitro Study.Front Vet Sci2021https://conductscience.org/library/papers/34671662PubMed
34583720Systematic literature review evaluating evidence and mechanisms of action for platelet-rich plasma as an antibacterial agent.J Cardiothorac Surg2021https://conductscience.org/library/papers/34583720PubMed

See all 27 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/29700554

GET https://conductscience.org/api/papers/v1/29700554/references?page=2